GLP-1 News and Insights

GLP-1 news and plain-English explainers for US patients: what Wegovy, Zepbound and the new GLP-1 pills really cost, how Medicare’s $50 GLP-1 copay works, what is changing for compounded semaglutide and tirzepatide, and how to get a prescription online. Every price has a date and a source.

Latest GLP-1 News and Insights

Get GLP-1 News and Price Changes by Email

A short email when prices change, the FDA acts on GLP-1s or we publish a new review.

We only use your email to send these updates. See our privacy policy. Unsubscribe anytime.

GLP-1 Insights: What’s Changing in 2026

A lot changed this year for people paying for GLP-1s: new cash prices, a Medicare program, the first weight-loss pills and tighter rules on compounding. Here is the short version, with a link to the full story for each.

  • Medicare covers some GLP-1s for $50 a month. The Medicare GLP-1 Bridge gives eligible Part D enrollees Wegovy, the Zepbound KwikPen or Foundayo for $50 per fill from July 1, 2026 through December 31, 2027.
  • You can buy brand-name GLP-1s for cash. Lilly and Novo Nordisk sell direct through LillyDirect and NovoCare, and brand-name weight-loss drugs cost $149 to $449 a month at the makers’ cash prices. See every price, channel by channel.
  • GLP-1 pills are here. The FDA approved the Wegovy pill in December 2025 and Foundayo in April 2026. Both cost $149 a month at starting doses on the makers’ cash programs. Compare the two pills.
  • Compounded GLP-1s are narrowing. Mass-made copies of semaglutide and tirzepatide have been off-limits since the FDA’s shortage grace periods ended in 2025, and in April 2026 the FDA proposed closing the large-batch (503B) route. See what is still legal.
  • Insurance coverage is still the exception. Only 19% of firms with 200 or more workers covered GLP-1s for weight loss in KFF’s 2025 survey. Check your plan and appeal a denial.
  • Getting a prescription online is routine. Telehealth visits cost about $25 to $299, or $49 to $149 a month in membership fees, before the drug. Read how online prescriptions work and where to buy injections safely.

How We Research These Articles

We start with primary sources: FDA and CMS records, drug labels, the manufacturers’ own price lists and the terms each provider publishes. We date every price, link to where it came from, and update an article when a price or a rule changes. Some providers we write about pay us a commission when readers sign up. That never decides what we publish or how we score anyone. See how we make money and our editorial policy.

  • Prices. We check the makers’ cash programs (LillyDirect and NovoCare), pharmacy prices and each telehealth provider’s own pricing page, and we re-check them every month.
  • Rules and coverage. We read FDA announcements, drug labels, CMS program pages and plan documents, and we note the date we checked each one.
  • Numbers. Survey results and trial data come from the original report, such as a KFF survey or the drug maker’s published trial, not from a news story about it.
  • Reader questions. We read what patients ask on forums such as Reddit and answer the questions that come up most often.
  • Corrections. If you spot an error, tell us. We fix it and update the date on the article.
GLP1Rating - Independent Editorial Reviews © 2026 All Rights reserved
GLP1Rating
Logo